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The terminal enzyme of the mitochondrial respiratory
chain, cytochrome oxidase, transfers electrons to
molecular oxygen, generating water. Within the
inner mitochondrial membrane, cytochrome oxidase
assembles into supercomplexes, together with other
respiratory chain complexes, forming so-called res-
pirasomes. Little is known about how these higher
oligomeric structures are attained. Here we report
on Rcf1 and Rcf2 as cytochrome oxidase subunits
in S. cerevisiae. While Rcf2 is specific to yeast,
Rcf1 is a conserved subunit with two human ortho-
logs, RCF1a and RCF1b. Rcf1 is required for growth
in hypoxia and complex assembly of subunits Cox13
and Rcf2, as well as for the oligomerization of a
subclass of cytochrome oxidase complexes into
respirasomes. Our analyses reveal that the cyto-
chrome oxidase of mitochondria displays intrinsic
heterogeneity with regard to its subunit composition
and that distinct forms of respirasomes can be
formed by complex variants.
INTRODUCTION
The majority of cellular ATP is generated by oxidative phosphor-
ylation within mitochondria. In this process, the respiratory chain
establishes a proton gradient across the inner membrane of
mitochondria that drives the F1FoATPase to generate ATP from
ADP and anorganic phosphate, which is subsequently trans-336 Cell Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc.ported out of mitochondria by the ADP/ATP carrier. The cyto-
chrome oxidase (complex IV) is the terminal enzyme of the
respiratory chain. It receives electrons from cytochrome c, trans-
ports two protons across the inner membrane, and reduces
molecular oxygen to water (Saraste, 1999; Tsukihara et al.,
1996; Yoshikawa et al., 2011). The cytochrome oxidase is func-
tionally highly conserved from bacteria to man but acquired
increased complexity with regard to its composition throughout
evolution. In human mitochondria it is comprised of three mito-
chondria-encoded membrane proteins (Cox1, Cox2, and Cox3)
that assemble with ten nuclear-encoded proteins into an intri-
cate membrane-embedded entity in a process that requires
numerous specific assembly factors (Carr and Winge, 2003;
Fontanesi et al., 2008; Herrmann and Funes, 2005; Mick et al.,
2011). Defects in cytochrome oxidase function, caused bymuta-
tions in structural subunits, inproper formation of the redox
centers, or the lack of functional assembly factors, lead to severe
neuromuscular disorders known as mitochondrial encephalo-
myopathies (DiMauro and Schon, 2003; Shoubridge, 2001;
Zeviani and Spinazzola, 2003).
The crystal structure of the bovine cytochrome oxidase
reveals a dimeric enzyme with COX6a (Cox13 in yeast) at the
interface of the two monomers (Tsukihara et al., 1996). In the
inner mitochondrial membrane, cytochrome oxidase does not
act as a single entity but associates with other complexes of
the respiratory chain into respirasomes, supercomplexes of
several respiratory chain complexes (Althoff et al., 2011; Scha¨g-
ger and Pfeiffer, 2000; Stuart, 2008). This oligomerization
enhances respiratory chain activity through spatial restriction
of electron carrier diffusion (Acı´n-Pe´rez et al., 2008). In Saccha-
romyces cerevisiae, cytochrome oxidase associates with the
bc1-complex (complex III), forming two distinct complexes that
can be separated by Blue native PAGE analyses, consisting of
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Cytochrome Oxidase Supercomplex Formationa single complex IV associated to a dimer of complex III (III2IV) or
two complex IVs associatedwith a complex III dimer (III2IV2). Due
to the presence of NADH dehydrogenase (complex I) in human
mitochondria, the oligomerization pattern is more complex.
Similarly, oligomerization has also been reported for the
F1FoATPase of mitochondria (Arnold et al., 1998). Several
specific dimerization factors have been identified that regulate
the oligomerization of the F1FoATPase in a process that appears
to be fine-tuned by the posttranslational modification of the
assembly factor Atp20 (Reinders et al., 2007). While oligomeriza-
tion appears to have little effect on the activity of the enzyme,
oligomers of the F1FoATPase have been found to be important
in inner mitochondrial membrane cristae organization (Paumard
et al., 2002; Rabl et al., 2009; Wagner et al., 2009). In contrast to
the F1FoATPase, no protein factors have thus far been identified
that specifically regulate respiratory chain supercomplex forma-
tion. Thus, the role of supercomplex formation in mitochondria is
still ill defined. However, cardiolipin, the hallmark phospholipid of
mitochondria, is important to stabilize mitochondrial membrane
protein complexes including respiratory chain supercomplexes
(Pfeiffer et al., 2003; Zhang et al., 2002, 2005). Thus, yeast mito-
chondria defective in cardiolipin synthesis display supercomplex
dissociation (Brandner et al., 2005). In Barth syndrome patients,
in which cardiolipin remodeling is affected, a similar destabiliza-
tion of supercomplexes is observed and believed to contribute to
the pathology of the disorder (McKenzie et al., 2006).
Here we identified Rcf1 and Rcf2 as two structural subunits of
the yeast cytochrome oxidase that interact with the bc1
complex. While Rcf2 is conserved among yeast species, Rcf1
possesses eukaryotic homologs including two human variants
(RCF1a and RCF1b). Yeast cells lacking Rcf1 are affected in
cytochrome oxidase function and display increased production
of reactive oxygen species (ROS). We find that Rcf1 is required
for assembly of the structural subunits Cox13 and Rcf2 into
cytochrome oxidase complexes. Moreover, Rcf1 is required for
respirasome formation, and loss of Rcf1 causes the selective
deficiency of supercomplexes consisting of a bc1 complex dimer
and two cytochrome oxidase complexes. Thus, Rcf1 is the first
protein mediating respirasome formation. Moreover, identifica-
tion of Rcf1 revealed that, in contrast to the established view,
mitochondria possess at least two different enzymatically active
cytochrome oxidase forms, which are distinguishable by their
protein composition. Both forms of the complex are indepen-
dently incorporated into respirasomes. Our analyses indicate
that a Cox13-containing isoform, that is selectively deficient in
rcf1D mitochondria, is required to protect the respiratory chain
from malfunction and thus ROS generation under hypoxic
conditions.
RESULTS
Identification of Rcf1 and Rcf2
In S. cerevisiae, complex III is found in a dimeric form and in
complex with one or two copies of complex IV, while the
F1FoATPase is found in a monomeric or a dimeric form, which
can be separated and analyzed by Blue native PAGE (BN-
PAGE) (Scha¨gger and Pfeiffer, 2000; Stuart, 2008). However,
the molecular composition of these complexes is still ill defined.
In addition to respiratory chain complexes, a large number ofCediverse proteins have been found to associate with respiratory
chain complexes within supercomplexes. Among these proteins
are, e.g., assembly factors of the respiratory chain (Mick et al.,
2007), translational regulators (Mick et al., 2010), mitochondrial
metabolite carriers (Dienhart and Stuart, 2008), the presequence
translocase (Saddar et al., 2008; van der Laan et al., 2006),
subunits of the import motor (Wiedemann et al., 2007), lipid-
modifying enzymes (Claypool et al., 2008), and fatty acid
b oxidation enzymes (Wang et al., 2010). To identify supercom-
plex-associated factors that could fall into one of the different
categories described above, we purified complex III/IV super-
complexes from digitonin-solubilized mitochondria by affinity
chromatography using a TAP-tagged version of the complex III
subunit Cor1 and a wild-type strain lacking a tag on Cor1 as
a control (van der Laan et al., 2006; Wiedemann et al., 2007).
As a second dimension of purification, we separated the isolated
complexes by BN-PAGE (Figure 1A). Protein complexes were
excised from the gel and subjected to in-gel digestion, and
peptides were analyzed by mass spectrometry. As expected,
we identified known structural subunits of complex III and
complex IV as well as a number of the known associated factors
(Table 1 and see Table S1 available online). However, we also
identified two uncharacterized proteins that we later termed
Rcf1 (YML030W) and Rcf2 (YNR018W) (Respiratory Supercom-
plex Factor 1/2). In a genome-wide screen for genes involved in
mitochondrial inheritance, these genes had been identified as
Aim31 and Aim38; however, a function had not yet been attrib-
uted (Hess et al., 2009). Moreover, a proteomic analysis of crude
mitochondrial extracts separated by BN-PAGE had suggested
comigration of these proteins with supercomplexes but ad-
dressed neither their function nor into which group of supercom-
plex-associated factors they could be assigned (Helbig et al.,
2009). We confirmed the mass spectrometric result by western
blot analyses of purified supercomplexes. Similar to the known
structural subunits of the respiratory chain, Rcf1 and Rcf2
were copurified with Cor1TAP (Figure 1B). Rcf1 is a protein of
18 kDa with two predicted transmembrane helices. Similarly,
Rcf2 consists of two predicted transmembrane helices and
has a size of 25 kDa (Figure 1C). Both proteins lack an obvious
N-terminal presequence for targeting into mitochondria. In
agreement, when both proteins were synthesized in reticulocyte
lysate and imported into isolated mitochondria, efficient in vitro
import was observed; however, no processing to a faster-
migrating mature formwas seen (Figure S1A). Carbonate extrac-
tion analyses of isolated mitochondria showed that Rcf1 and
Rcf2 were resistant to alkaline treatment and remained in the
sediment together with integral membrane proteins, but both
proteins were released uponmembrane solubilization with Triton
X-100 (Figure 1D). Antibodies against Rcf1 and Rcf2 were
directed against C-terminal domains of the proteins. When mito-
chondria were treated with proteases, both proteins remained
unaffected. However, the antigenic epitopes of Rcf1 and Rcf2
became accessible to protease treatment when the outer
membrane was ruptured by osmotic swelling (mitoplast forma-
tion), and no faster-migrating proteolytic fragments were de-
tected (Figure 1E and Figure S1B). We concluded that Rcf1
and Rcf2 are integral proteins of the mitochondrial inner
membrane and expose their C termini to the intermembrane
space.ll Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc. 337
Figure 1. Purification of Respiratory Chain Supercomplexes and Identification of Rcf1 and Rcf2
(A) Mitochondria isolated from wild-type (WT), and cor1TAP strains were solubilized in 1% digitonin and subjected to IgG chromatography. Upon TEV protease
cleavage, eluates were analyzed by BN-PAGE and subjected to mass spectrometric analysis.
(B) Eluates from (A) were analyzed by SDS-PAGE, western blotting, and immunodecoration. Total, 10%; eluate, 100%.
(C) Schematic representation of Rcf1 and Rcf2 proteins. Black boxes, predicted transmembrane domains (TM); numbers indicate amino acids.
(D) Yeast mitochondria were subjected to carbonate extraction or lysed with 1% Triton X-100 followed by separation into pellet (P) and supernatant (S); total (T).
Samples were subjected to western blot analysis.
(E) Yeast mitochondria were left untreated, swollen, or lysed with 1% Triton X-100; treated with Proteinase K where indicated; and subjected to SDS-PAGE and
western blotting.
(F) Immunofluorescence analysis of U2-OS cells using cyclophilin D and RCF1a- and RCF1b-specific antibodies. Scale bar, 10 mm.
(G) HEK293 mitochondria were subjected to carbonate extraction. Pellet (P), supernatant (S), total (T).
(H) HEK293 mitochondria were treated as in (E). See also Figure S2.
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Rcf1 homologs were identified from yeast to plants, mouse,
and human (Figures S2A–S2C). Two variants of Rcf1 could be
identified in silico in human (RCF1a [Q9Y241-2] and RCF1b
[Q9BW72]) and mouse. We assessed expression in different
murine tissues by quantitative real-time PCR analyses and found
that RCF1a and RCF1b were especially expressed in metaboli-
cally active tissues such as heart, liver, and kidney (Figure S1C).
We next addressed the subcellular localization of RCF1a and
RCF1b by immunofluorescence analysis and found both fully co-
localizedwithmitochondrial cyclophilin D (Figure 1F). RCF1a and
RCF1b were present in isolated human mitochondria and
behaved as integral membrane proteins in carbonate extraction
similar to TIM23 and TOM70, while the peripheral membrane
protein TACO1 was released from membranes at pH 11.5 (Fig-
ure 1G). Protease protection experiments revealed that RCF1a
and RCF1b remained protected in mitochondria. However, while
RCF1b became accessible to protease treatment in mitoplasts,
RCF1a was not affected by the treatment, and no stable degra-
dation products were detected (Figure 1H and Figure S1D).338 Cell Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc.Thus, human RCF1a and RCF1b are inner mitochondrial
membrane proteins of which RCF1b displays topology similar
to that of yeast Rcf1 and is partially exposed to the intermem-
brane space.
Rcf1 and Rcf2 Are Associated with Cytochrome Oxidase
Until this point, our analyses had yet to reveal if Rcf1 and Rcf2
were associated with complex III or complex IV. Therefore, we
imported both proteins into isolated mitochondria. SDS-PAGE
analyses showed that both proteins were efficiently transported
into mitochondria in a membrane potential-dependent manner
(Figure S1A). After import, mitochondria were reisolated, solubi-
lized, and protein complexes separated by BN-PAGE. Rcf1 and
Rcf2 assembled predominantly into two high molecular weight
protein complexes. These complexes comigrated with respira-
tory chain supercomplexes consisting of complex III and IV
(Figure 2A). This migration pattern was reminiscent of complex
IV, as no complexes were apparent that corresponded in size to
complex III dimers. The less abundant lower molecular weight
complexes of Rcf1 and Rcf2 likely represent assembly
Table 1. Proteins of Respiratory Chain Supercomplexes Foundby
Cor1TAP Affinity Purification
Subunits of
Cytochrome c
Reductase, bc1
Subunits of
Cytochrome c
Oxidase, COX
Assembly Factors
and Associated
Proteins
COR1/YBL045C COX1/Q0045 CBP3/YPL215W
QCR2/YPR191W COX2/Q0250 CBP4/YGR174C
QCR6/YFR033C COX3/Q0275a SHY1/YGR112W
QCR7/YDR529C COX4/YGL187C COX11/YPL132W
QCR8/YJL166W COX5a/YNL052W COX14/YML129C
QCR9/YGR183C COX5b/YIL111W COX16/YJL003W
RIP1/YEL024W COX6/YHR051W TIM21/YGR033C
COB/Q0105 COX7/YMR256C MDM38/YOL027C
CYT1/YOR065W COX8/YLR395C AAC2/YBL030C
COX9/YDL067C PET54/YGR222W
COX12/YLR038C
COX13/YGL191W
COX26/YDR119W-A
RCF1/YML030W
RCF2/YNR018W
aDetected only in BN-PAGE.
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Cytochrome Oxidase Supercomplex Formationintermediates of the two imported proteins. To support com-
plex IV association, we imported both proteins into mutant
mitochondria. cox4D mitochondria lack mature complex IV,
while cyt1D mitochondria are deficient in complex III. In
cox4Dmitochondria, complex III is found exclusively as a dimer,
while in cyt1D mitochondria complex IV displayed as two com-
plexes of different signal intensity between 230 and 440 kDa
(Figure 2B, lanes 14 and 16). Rcf1 and Rcf2 were imported
with similar efficiency into mutant mitochondria (Figure S1E).
However, when assembled Rcf1 and Rcf2 were analyzed
by BN-PAGE, they exhibited migration similar to Cox4 and
Cox13 in cyt1D mitochondria but did not assemble into
high molecular weight complexes in cox4D mitochondria
(Figure 2B).
To address if human RCF1a and RCF1b were also genuine
subunits of complex IV in human mitochondria, we first im-
ported human RCF1b into isolated human mitochondria
in vitro. The protein assembled in a membrane potential-depen-
dent manner into a complex of approximately 450 kDa that
comigrated with monomeric complex IV and RCF1a as visual-
ized by western blotting (Figure 2C). Moreover, a fraction of
RCF1a was also detected in respiratory chain supercomplexes
in human mitochondria by western blotting. In addition, immu-
noprecipitation experiments using antibodies against holo-
complex IV and the F1Fo-ATPase as a control specifically
copurified RCF1a and RCF1b with complex IV (Figure 2D).
Thus, Rcf1 and Rcf2 are subunits of complex IV and supercom-
plexes in yeast. Similarly, RCF1a and RCF1b are constituents of
human complex IV.
Loss of Rcf1 Affects Cytochrome Oxidase Function
and Promotes ROS Generation
To assess the function of Rcf1 and Rcf2 in regards to respiratory
chain activity, we generated gene deletion mutants. While Rcf1Ceand Rcf2 were dispensable for growth of yeast cells on ferment-
able carbon sources, rcf1D displayed growth defects on nonfer-
mentablemedium such as glycerol. In the course of analyses, we
recognized that the growth phenotype of rcf1D cells was exacer-
bated when plates were grown under low-oxygen conditions
(Figure 3A). This defect was less pronounced than that observed
in a respiratory-deficient mutant such as cox4D (affected in
a core subunit of the complex) but significantly more dramatic
than that of cox13D cells (affected in a peripherally localized
protein), which displayed growth behavior close to wild-type.
In contrast to rcf1D cells, rcf2D and rcf2D/cox13D doublemutant
cells displayed growth behavior similar to that of cox13D
cells (Figure 3A and Figure S3A). To support our conclusion
that rcf1D cells were especially sensitive to hypoxia, we grew
wild-type and rcf1D cells on fermentable carbon source in a
fermentor under normoxic and hypoxic conditions. While both
strains displayed similar division time under normoxia, rcf1D
cells were severely affected under hypoxic growth conditions
(Figure 3B).
We compared the steady-state protein levels of selected
mitochondrial proteins between wild-type, rcf1D, and rcf2D by
western blotting. Most proteins were similar in all three strains;
however, the amount of Cox13 was dramatically reduced in
rcf1D mitochondria (Figure 3C). In cox13D and rcf2D/cox13D
mitochondria the levels of Rcf1 were not affected (Figures S3B
and S3C). We assayed O2 consumption in wild-type and mutant
mitochondria with a Clark oxygen electrode. rcf1Dmitochondria
displayed drastically reduced oxygen consumption, similar to
the defect observed upon loss of Cox13 (Figure 3D). In contrast,
rcf2D mitochondria resembled wild-type mitochondria with
regard to oxygen reduction, while rcf2D/cox13D double mutant
mitochondria were similar tomitochondria from a cox13Dmutant
(Figure S3D). Enzyme activity assays demonstrated that rcf1D
and cox13D cells were specifically defective in cytochrome
oxidase activity, but rcf2D mitochondria were not affected (Fig-
ure 3E). Accordingly, Rcf1 is required for cytochrome oxidase
activity to a similar extent as Cox13, but Rcf2 appears to be
dispensable for its activity under the conditions used in this
study. Interestingly, when we measured mitochondrial enzyme
activities, we recognized a significant reduction in aconitase
activity in rcf1D and rcf2Dmitochondria (Figure 3F), even though
the amount of aconitase (Aco1) was comparable to wild-type
(Figure 3C). Since the 4Fe-4S cluster of aconitase is especially
sensitive to superoxide (O2
) (for review, see Raha and
Robinson, 2000), we addressed if the mutant mitochondria
displayed overall increased ROS production using H2DCFDA
(dichlorodihydrofluorescein diacetate) that detects a broad
range of different ROS. While rcf1D and rcf2D mitochondria
displayed a drastic increase in ROS generation compared
to wild-type mitochondria, cox13D mitochondria showed an
intermediate phenotype (Figure 3G). In contrast, mitochondria
that lacked Cox1, the heme-containing core subunit of complex
IV, showed wild-type-like ROS generation (Figure S3E). Thus,
Rcf1, Rcf2, and Cox13 appear to be uniquely important constit-
uents of complex IV that protect mitochondria against ROS
generation by the respiratory chain. Based on these findings,
we asked if RCF1a and RCF1b were able to substitute for
a lack of Rcf1 in yeast mitochondria. Expression of RCF1b but
not RCF1a reproducibly improved the growth phenotype ofll Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc. 339
Figure 2. Rcf1 and Rcf2 Associate with Cytochrome Oxidase
(A) Radiolabeled Rcf1 and Rcf2 were imported into isolated yeast mitochondria in the presence or absence of membrane potential (Dc) for indicated times.
Samples were treated with Proteinase K, solubilized in 1% digitonin buffer, and analyzed by BN-PAGE and digital autoradiography. For comparison, solubilized
mitochondria were analyzed by BN-PAGE, followed by western blotting and immunodecoration.
(B) Radiolabeled Rcf1 and Rcf2 were imported into isolated yeast mitochondria from WT, cox4D, and cyt1D cells and analyzed as in (A).
(C) Radiolabeled RCF1b was imported into mitochondria isolated from HEK293 cells, in the presence or absence of membrane potential (Dc), treated with
Proteinase K, solubilized in digitonin-buffer. Samples were analyzed by BN-PAGE and digital autoradiography. For comparison, mitochondria isolated from
HEK293 cells were solubilized in digitonin and analyzed by BN-PAGE, followed by western blotting and immunodecoration.
(D) Coimmunoprecipitation of cytochrome oxidase (COX) and F1FoATPase from digitonin-solubilized mitochondria isolated from HEK293 cells. Total, 1.5%;
elution, 100%. See also Figure S1.
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Cytochrome Oxidase Supercomplex Formationrcf1D cells (Figure 3H). We noted that the yeast RCF1 only
partially complemented the growth defect of the deletion strain
due to slightly reduced expression levels from the plasmid,
suggesting that the amount of Rcf1 was rate limiting. Therefore,
we analyzed complementation of rcf1D by human and yeast
RCF1 with regard to ROS production under nonlimiting
expression levels. Upon expression of Rcf1 and RCF1b in
rcf1D, ROS production was drastically reduced, while expres-
sion of RCF1a had no effect on the mutant phenotype (Fig-
ure S4A). Thus, RCF1b is able to substitute Rcf1 functions in
yeast mitochondria.
Assembly of Cox13 and Rcf2 Depends on Rcf1
Cox13 is a conserved structural subunit of complex IV, which
localizes to the periphery of the complex in the crystal structure
of bovine complex IV (Tsukihara et al., 1996). We speculated that
the reduced amount of Cox13 observed in rcf1D mitochondria
was due to an import or assembly defect. Therefore, we assayed340 Cell Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc.assembly of Cox13, Rcf1, and Rcf2 in the different mutants. We
synthesized and radiolabeled Cox13, Rcf1, and Rcf2 in reticulo-
cyte lysate and performed in vitro import into wild-type, cox13D,
rcf1D, and rcf2D mitochondria. After import, mitochondria were
solubilized in digitonin buffer and complexes separated on
BN-PAGE. Rcf2 efficiently assembled into supercomplexes in
wild-type mitochondria, but assembly was blocked in the
absence of Cox13 (Figure 4A, upper panel) or Rcf1 (Figure 4B,
upper panel). To exclude the possibility that assembly defects
were indirectly caused by a block of precursor import, we
analyzed samples by SDS-PAGE and found that the import of
Rcf2 was similar in mutant and wild-type mitochondria (Figures
4A and 4B, lower panels). Assembly of Cox13 into supercom-
plexes was similar to wild-type in rcf2Dmitochondria (Figure 4C,
upper panel) but completely blocked in rcf1D mitochondria
(Figure 4D, upper panel). Again, import of Cox13 as assayed
by SDS-PAGE, was unaffected in both mutants (Figures 4C
and 4D, lower panels). Lastly, we analyzed import and assembly
Figure 3. rcf1D Cells Have Reduced Respiratory Efficiency
(A) Growth test of wild-type (WT), rcf1D, rcf2D, cox13D, and cox4D yeast cells.
(B) Growth rate analysis of wild-type (WT) and rcf1D yeast cells in liquid medium.
(C) Isolated wild-type (WT), rcf1D, and rcf2D mitochondria were subjected to SDS-PAGE and analyzed by western blotting.
(D) Oxygen consumption measurements of mitochondria isolated from indicated strains.
(E) Mitochondrial enzyme assays of NADH-cytochrome c reductase, cytochrome c oxidase, and malate-dehydrogenase.
(F) Aconitase activities of isolated mitochondria.
(G) Mitochondrial ROS production in indicated strains. (D)–(G) Means of three independent measurements (SEM, n = 3).
(H) Complementation of yeast rcf1D on nonfermentable medium with yeast yRCF1 gene and human hRCF1A and hRCF1B genes. SD, selective glucose; SG,
selective glycerol. See also Figure S3.
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rcf1D mitochondria (Figures 4E and 4F). In conclusion, we find
that Rcf1 is required for efficient assembly of Cox13 and Rcf2
into supercomplexes. Furthermore, assembly of Rcf2 alsoCedepends on the presence of Cox13. Neither Cox13 nor Rcf1
assembly is Rcf2 dependent. These analyses suggest that the
three proteins assemble in a successive manner with Rcf1 being
first, followed by Cox13 and Rcf2.ll Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc. 341
Figure 4. Assembly of Cox13 and Rcf2 into Cyto-
chrome Oxidase Is Rcf1 Dependent
Radiolabeled Rcf2, Cox13, and Rcf1 were imported into
isolated yeast mitochondria in the presence or absence of
Dc for indicated times and treated with Proteinase K.
Samples were lysed in 1% digitonin buffer, analyzed by
BN-PAGE or SDS-PAGE and digital autoradiography.
Rcf2 was imported into WT/cox13D mitochondria (A) and
WT/rcf1Dmitochondria (B). Cox13 was imported into WT/
rcf2D mitochondria (C) and WT/rcf1D mitochondria (D).
Rcf1 was imported into WT/cox13D mitochondria (E) and
WT/rcf2D mitochondria (F).
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Cytochrome Oxidase Supercomplex FormationRcf1 Is Required for Formation of Supercomplexes
in Mitochondria
To address the organization of respiratory chain supercom-
plexes at steady state, we solubilized cox13D, rcf1D, and rcf2D
mitochondria in digitonin-containing buffer and performed
BN-PAGE analyses. All mutant mitochondria possessed respira-
tory chain complexes III and IV. However, rcf1D mitochondria
displayed a dramatic loss of III2IV2 complexes compared to
wild-type, cox13D, rcf2D, cox13D/rcf2D, and taz1D (involved in342 Cell Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc.cardiolipin biosynthesis) mitochondria (Fig-
ure 5A; Figures S4B and S4C). While Cox13
and Rcf2 assembly was severely affected in
rcf1D mitochondria (see above), at steady state
a low amount of both proteins was present in
respiratory chain complexes of rcf1Dmitochon-
dria (Figure 5A, lanes 18 and 22). This finding
suggests that Rcf1 is important but not essential
for Cox13 and Rcf2 assembly and that a small
amount of Rcf2 and Cox13 can accumulate in
the complex in vivo. In cox13D mitochondria,
Rcf2 was not recovered in supercomplexes
but accumulated in an unassembled, probably
monomeric form that was apparent in the
low molecular weight range of BN-PAGE (Fig-
ure 5A, lane 20). (The antibody against Rcf1
was unable to detect the protein in BN-PAGE
analyses.) Most striking was the observation
that Rcf1 was specifically required for formation
of respiratory chain supercomplexes. The
amount of III2IV2 was drastically reduced, and
at the same time III2IV and free complex III2
accumulated (Figure 5A), suggesting that III2IV2
complexes dissociate in the absence of Rcf1
or are not formed efficiently. This phenotype
was fully reversed by expression of Rcf1 in
rcf1D cells, but not by expression of RCF1a or
RCF1b (Figure S4D).
If Rcf1 was generally required for association
of complex IV to complex III2, one would expect
full dissociation of supercomplexes into mono-
meric complex IV and dimeric complex III in
mutant strains. Thus, we considered two ex-
planations for the observed phenotype: (1)
rcf1D mitochondria could simply possess less
complex IV so that the equilibrium betweensupercomplexes is altered in favor of III2IV formation; (2) complex
IV monomers that associate with complex III dimers are not
identical in their composition, and therefore only a subfraction
of complexes is affected by a lack of Rcf1.
To experimentally address the existence of distinct forms of
complex IV, we first generated Cox4, Rcf2, and Cox13 fusions
with ZZ tags and expressed the fusions in yeast from the chro-
mosomal locus. Purification of Cox4ZZ, Cox13ZZ, and Rcf2ZZ
from digitonin-solubilized mitochondria was possible and led
Figure 5. Formation of Respiratory Chain
Supercomplexes Depends on Rcf1
(A) Mitochondria isolated from indicated strains
were lysed in 1% digitonin buffer, subjected to
BN-PAGE, and analyzed by western blotting.
(B) Cox4ZZ, Cox13ZZ, and Rcf2ZZ complexes were
isolated from digitonin-solubilized mitochondria
via IgG chromatography, analyzed by SDS-PAGE
and western blotting. Total, 10%; eluate, 100%.
(C) Isolation of Cox4ZZ, Cox13ZZ, and Rcf2ZZ
complexes was performed as in (B). Bound
complexes were released from the column by TEV
protease cleavage, analyzed by BN-PAGE and
western blotting. Eluate fractions are presented.
See also Figure S4.
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ure 5B). However, while Cox4ZZ and Cox13ZZ efficiently isolated
complex IV and complex III, Rcf2ZZ was only associated with
a fraction of supercomplexes under these conditions (Figure 5B,
lane 7). This agreed with the BN-PAGE analyses in which a pool
of Rcf2 migrated as amonomeric, unassembled form at the front
of the gel (Figure 5A, lane 17). Moreover, when we purified
Cox4ZZ-, Cox13ZZ-, and Rcf2ZZ-containing complexes from digi-
tonin-solubilizedmitochondria and analyzed these by BN-PAGE,
Rcf2 only copurified a small fraction of supercomplexes
compared to Cox4 and Cox13 (Figure 5C). This finding indicates
that Rcf2 is a substoichometric subunit of supercomplexes.
Distinct Forms of Cytochrome Oxidase Exist in
Mitochondria
To dissociate supercomplexes into complex IV monomers and
complex III dimers (Scha¨gger and Pfeiffer, 2000), we solubilized
mitochondria in dodecylmaltoside-containing buffer and iso-
lated Cox4ZZ- and Cox13ZZ-containing complexes by IgG
chromatography. In comparison to Cox4ZZ isolations, Cox13ZZ
isolations copurified significantly fewer complex IV subunits.
This became especially apparent upon comparison of the
unbound fractions, which were depleted for complex IV subunits
in Cox4ZZ isolations, but not in Cox13ZZ (Figure 6A). Rcf1 and
Rcf2 dissociated from complex IV under these solubilization
conditions. Only a fraction of Rcf1 (approximately 20%) could
be detected in Cox4ZZ-purification samples, while Rcf2 fully
dissociated (Figure 6A). When we isolated complex III via Cor1Cell Metabolism 15, 336–3under these conditions, small amounts
of Rcf1 and Rcf2 (approximately 5%)
but not Cox13 or other subunits of
complex IV copurified (Figure S4E). In
summary, these analyses suggested
that Cox13 was only associated with
a subfraction of complex IV in mitochon-
dria. Moreover, a fraction of Rcf1 and
Rcf2 is associated with complex III, indi-
cating that besides their preferential
association with complex IV they can
also interact with complex III. Thus, we
hypothesize that Rcf1 and Rcf2 are likely
to be present at the interface of complex
III/IV oligomers.Despite the fact that the steady-state protein analyses of
rcf1Dmitochondria had not indicated differences in the amounts
of complex IV subunits compared to wild-type, with the excep-
tion of Cox13, we assessed directly the amount of complex IV
and its organization in mutant mitochondria after solubilization
in dodecylmaltoside-containing buffer. Solubilized complexes
were separated by BN-PAGE and analyzed by western blotting.
Cox1 was detected in distinct complexes of different size
(termed IV and IV* here, Figure 6B). Depending on the resolution
of the gel, IV* complexes migrated as one or two complexes.
However, the number of IV* complexes was significantly fewer
as compared to IV when an antibody against the core subunit
Cox1 was used. In contrast to the core subunit Cox1, Cox13
was exclusively present in the slower-migrating IV* complexes
(Figure 6B, lane 5). While complex IV levels were not significantly
altered in rcf1D mitochondria, loss of Rcf1 caused a selective
lack of the IV* forms, while the IV form remained largely unaf-
fected. This defect was Rcf1 specific and not related to the
absence of Cox13, since Cox1 was detected in IV and IV*
complexes in cox13Dmitochondria (Figure 6B). For comparison,
we used NP-40 for solubilization and similarly observed two
distinct forms of complex IV, of which only the larger one con-
tained Cox13 (Figure 6C). The apparent migration differences
of the complexes in the two detergents is likely due to differences
in micellar size.
Our analyses did not rule out the possibility that the selective
detection of Cox13 in the IV* complex was due to differential
accessibility of the antigenic epitope in the two complexes.47, March 7, 2012 ª2012 Elsevier Inc. 343
Figure 6. Complex IV Exists in Distinct
Forms
(A) Cox4ZZ and Cox13ZZ complexes were isolated
from DDM-solubilized mitochondria via IgG chro-
matography, analyzed by SDS-PAGE and western
blotting. Total, unbound, 25%; elution, 100%.
(B) Mitochondria isolated from indicated strains
were lysed in 0.6% DDM buffer, subjected to BN-
PAGE, and analyzed by western blotting.
(C) Wild-type (WT) mitochondria were lysed in
0.6% DDM- or 0.5% NP-40-buffer, analyzed by
BN-PAGE.
(D) Mitochondria isolated from wild-type (WT)
and cox13ZZ strains were solubilized in 0.6%
DDM buffer, subjected to BN-PAGE and western
blotting.
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mass of the Cox13-containing complexes. After solubilization
in DDM-containing buffer, complexes were analyzed by
BN-PAGE. Compared to wild-type mitochondria, Cox13ZZ
mitochondria showed a specific mass shift of complex IV*, while
complex IV remained unaltered (Figure 6D). This finding supports
the conclusion that Cox13 is selectively present in complex IV*.
Accordingly, Cox13 is a constituent of a defined subclass of
cytochrome oxidase complexes in mitochondria. Rcf1 is specif-
ically required for the formation of this complex isoform. We
conclude that the lack of the Cox13-containing isoforms of
complex IV in rcf1D mitochondria leads to the absence of the
III2IV2 supercomplex.
DISCUSSION
The identification of respirasomes has changed our view on the
organization of the respiratory chain and impacted the concept
of electron shuttling between complexes (Acı´n-Pe´rez et al.,
2008; Stuart, 2008; Wittig and Scha¨gger, 2009). However, a
mechanistic basis of supercomplex formation between respira-
tory chain complexes has remained undefined. While it is well
documented that the lipid environment contributes to the344 Cell Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc.stabilization of such supercomplexes,
protein constituents required for the
association between complexes have
only been found in the case of the F1Fo-
ATPase (Arnold et al., 1998; Fontanesi
et al., 2006; Pfeiffer et al., 2003; Zhang
et al., 2002). However, a number of recent
analyses have revealed that respiratory
chain supercomplexes are in fact a yet-
unresolved heterogeneous population of
complexes in which a number of acces-
sory factors can associate to respiratory
chain oligomers (see above). This fact
hampers the identification of specific olig-
omerization factors. Moreover, the lack
of specific mutants that affect respiratory
chain oligomerization represents an
obstacle in addressing the physiological
function of respirasomes inmitochondria.Here we have identified Rcf1 and Rcf2 as two new subunits of
the cytochrome oxidase. Rcf1 is a conserved protein with two
variants in human mitochondria RCF1a and RCF1b. Upon
expression in rcf1D mutant cells, RCF1b is able to alleviate
growth defect and ROS production, indicating functional
complementation. We show that Rcf1 is specifically required
for supercomplex formation between cytochrome oxidase and
bc1 complexes in the inner membrane of mitochondria. Interest-
ingly, a lack of Rcf1 does not affect all cytochrome oxidase
complexes similarly, and a subset of complexes is still able to
associate with bc1 complexes in the absence of Rcf1. This
phenotype is explained by the unexpected observation in which
cytochrome oxidase exists in different forms that can be defined
by the absence or presence of Cox13 (COX6a in human). Our
analyses demonstrate that only a fraction of respiratory chain
complexes contain Cox13, while the majority of cytochrome
oxidase complexes are Cox13-free. Interestingly, the Cox13-
containing form of the complex has been crystallized and
displays a peripheral position of Cox13 (Tsukihara et al., 1996).
Despite the fact that Rcf1 is a conserved constituent of the
cytochrome oxidase complex, it was not identified in the X-ray
structure. Our analyses show that complex association of Rcf1
and Rcf2 is affected by dodecylmaltoside treatment. Thus, it is
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Cytochrome Oxidase Supercomplex Formationlikely that proteins are lost from the complex under the purifica-
tion conditions that have been used in previous analyses.
We show that Rcf1 is required for cytochrome oxidase activity
and that lack of Rcf1 function leads to growth defects on nonfer-
mentable carbon sources. The magnitude of the defect in
cytochrome oxidase activity resembles that observed in mito-
chondria lacking Cox13. However, rcf1D cells display a more
severe growth defect on nonfermentable carbon sources than
do cox13D cells. Our analyses show that Rcf1 is specifically
required for growth of yeast cells under hypoxic conditions. In
contrast, Rcf2 is not required for cytochrome oxidase activity,
at least not under the conditions used here. A clear Cox13
(COX6a) function has so far not been assigned, but the protein
has been implicated in an ATP-dependent modulation of enzyme
activity (Taanman and Capaldi, 1993). Interestingly, human
COX6a displays tissue specificity and thus might be important
for the fine-tuning of the complex with regard to the specific
demands of the tissue (Fontanesi et al., 2008; Vijayasarathy
et al., 1998). In line with the observed defects in cytochrome
oxidase activity, we find that Rcf1 is required for efficient
assembly of Cox13 and Rcf2, and that Cox13 is required for
Rcf2 biogenesis, in contrast to Rcf1. Thus, the defect in cyto-
chrome oxidase activity in rcf1D mitochondria is likely coupled
to Cox13 function.
While Rcf2 deficiency did not cause an appreciable defect in
the organization or activity of cytochrome oxidase in our anal-
yses, we detected a significant increase in the production of
ROS in rcf2Dmitochondria. The same extent of ROS generation
was measured in rcf1D mitochondria, while cox13D mitochon-
dria displayed an intermediate phenotype as compared to
wild-type. ROS production did not correlate with the defects
in cytochrome oxidase activity, since this was not affected in
rcf2D mitochondria and ROS production was not increased in
cox1 mitochondria or in other tested coxmutant mitochondria.
Moreover, the ROS phenotype also does not explain the
selective growth defects seen for the mutants, since only rcf1D
cells showed a growth defect under hypoxic conditions. How
can these observations be reconciled with the fact that Cox13
marks a specific form of cytochrome oxidase and that Rcf1 but
not Rcf2 is required for the formation of this complex? If one
takes into consideration the observed dependencies of Cox13,
Rcf1, and Rcf2 with regard to their assembly, it is likely that
these proteins are present in the same cytochrome oxidase
complexes. Unfortunately, Rcf2 fully dissociates from the IV*
complex under conditions in which the complex can be
dissected. Moreover, only small amounts of Rcf1 remain associ-
ated with Cox13 under these conditions (Figure 5C, lane 8).
Therefore, only circumstantial evidence exists that these three
proteins are constituents of the same complex. The fact that
a fraction of Rcf1 and Rcf2, but not Cox13, remains associated
with complex III when supercomplexes are dissociated by dode-
cylmaltoside suggests that these two proteins localize to the
interface between complexes III and IV and are able to contact
both. Considering the phenotype of rcf1D, it is tempting to spec-
ulate that Rcf1 could act as a physical link between complexes.
However, the dramatic loss of III2/IV2 supercomplexes in rcf1D
mitochondria cannot just be reconciled with the loss of complex
IV*, since this complex represents the less abundant form of
complex IV. However, it is conceivable that Rcf1 is not solelyCerequired to associate the IV* complex with complex III but could
also act in associating the IV complex with complex III.
The presence of a specific isoform of complex IV, termed IV*,
was an unexpected observation. As this complex is absent in
rcf1D mitochondria and likely to contain Rcf2 and Cox13, we
propose that the IV* complex serves to protect the respiratory
chain from ROS generation and that a lack of any of the three
proteins leads to malfunction and thus ROS production,
probably in a catalytic manner. To confirm this model it will be
important to further dissect the composition of the IV* complex
and to devise a strategy to preserve accessibility to biochemical
analyses in the future.
EXPERIMENTAL PROCEDURES
Protein Complex Isolation and Depletion Assay
Mitochondria containing TAP- or protein A-tagged proteins (10 mg for prepar-
ative scale, 1 mg or 0.5 mg for analytical scale, and 0.2 mg for depletion assay)
were solubilized at 4C in soulubilization buffer (100 mMNaCl, 20 mM Tris/HCl
[pH 7.4], 5% [v/v] glycerol, 0.5 mM EDTA, 1% [w/v] digitonin, or 0.6% [w/v]
DDM). After clarifying-spin samples were incubated with IgG Sepharose.
Upon extensive washing with solubilization buffer containing 0.3% (w/v)
digitonin or 0.2% (w/v) DDM, bound proteins were eluted by TEV protease
cleavage or with SDS sample buffer, without b-mercaptoethanol to prevent
release of IgG chains from the Sepharose, and subsequently analyzed by
BN-PAGE or SDS-PAGE, western blotting, and mass spectrometry.
Immunoprecipitation
Immunoprecipitation of human mitochondrial complexes was performed
either with beads coupled with anti-Complex IV antibodies or anti-Complex
V antibodies (Invitrogen). Isolated mitochondria (1 mg) from HEK293T cells
were solubilized at 4 C in IP buffer (20 mM Tris [pH 7.4], 50 mM NaCl,
0.5 mM EDTA, 10% [w/v] glycerol, 1% [w/v] digitonin, 1 mM PMSF). After
a clarifying spin, samples were incubated with the individual antibody-coupled
beads for 1 hr at 4C. Samples were washed ten times with W buffer (IP buffer
with 0.3% [w/v] digitonin, 1 mM PMSF). Bound proteins were eluted with SDS
sample buffer.
Protein Localization Analysis
Isolated mitochondria were converted to mitoplasts by hypotonic swelling in
EM buffer (1 mM EDTA, 10 mM MOPS [pH 7.2]) or lysed in 1% Triton X-100
and then treated with Proteinase K. Mitochondria were subjected to extraction
in 0.1 M Na2CO3 (pH 11.5 or pH 10.8), or 1% Triton X-100 supplemented with
150 mM NaCl, and then centrifuged at 45,000 rpm at 4C for 45 min. Samples
were precipitated with TCA and analyzed by SDS-PAGE and western blotting.
Immunofluorescence Assay
Immunofluorescence assay was performed according toWurm et al. (2010). In
brief, bone marrow U2-OS cells were grown on coverslips, fixed by incubation
of coverslips for 5–10 min in 8% paraformaldehyde (PFA), and permeabilized
by incubation in 0.5% (v/v) Triton X-100 for 5 min. Rabbit antisera against
RCF1a (N-terminal peptide; Santa Cruz Biotech.) and RCF1b (whole protein)
and mouse antisera against cyclophilin D were used at dilution 1:400. For
detection, Alexa Fluor 488 conjugated goat anti-rabbit IgG and Alexa Fluor
594 conjugated goat anti-mouse IgG (Invitrogen) were used in dilution 1:500.
Images were prepared using a microscope. Fluorescence microscopy was
performed with a beam-scanning confocal microscope (TCS SP5, Leica
Microsystems CMS GmbH, Wetzlar, Germany) equipped with 1.4 NA oil
immersion lenses (1003; HCX PL APO, Leica). The confocal pinhole was set
to 1 airy unit. Dual color images were obtained by sequential scanning. The
images are maximum projections of z stacks. Except for contrast stretching,
no image processing was applied.
In Vitro Import into Mitochondria
Mitochondrial precursor proteins were synthesized in rabbit reticulocyte lysate
(Promega) in the presence of [35S] methionine. Mitochondria were incubatedll Metabolism 15, 336–347, March 7, 2012 ª2012 Elsevier Inc. 345
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Cytochrome Oxidase Supercomplex Formationwith precursor proteins in import buffer (Ryan et al., 2001) in the presence of
2 mM ATP, 2 mM NADH, and ATP-regeneration system (5 mM creatine
phosphate and 0.1 mg/ml creatine kinase). The import reaction was stopped
on ice by dissipation of Dc with 8 mM antimycin A, 1 mM valinomycin, and
10 mM oligomycin. For assembly assays, mitochondria were lysed in 1%
digitonin buffer and processed for BN-PAGE.
BN-PAGE Electrophoresis
Mitochondria were solubilized in buffer (20 mM Tris-HCl [pH 7.4], 0.1 mM
EDTA, 50 mM NaCl, 10% [v/v] glycerol, and 1 mM PMSF) containing digitonin
(1% [w/v]), DDM (0.6% [w/v] DDM), or NP-40 (0.5% [v/v] NP-40) and incubated
for 15 min at 4C. Following a clarifying spin at 16,000 3 g for 10 min at 4C,
supernatants were mixed with 103 Blue native sample buffer (100 mM
Bis-Tris [pH 7.0], 5% [w/v] Coomassie Brilliant Blue G-250, and 500 mM
amino n-caproic acid). Polyacrylamide blue native gradient gels (4%–10%,
4%–13%, or 6%–10%) were used.
Miscellaneous
Standard techniques were used for SDS-PAGE and western blotting to PVDF
membranes. Visualization of antibody-protein complexes was achieved by
enhanced chemiluminescence (GEHealthcare). All protocols regarding mouse
organ explantations were approved by the Niedersa¨chsische Landesamt
fu¨r Verbraucherschutz und Lebensmittelsicherheit (T11/07) and conform with
the Directive 2010/63/EU of the European Parliament.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, one table, Supplemental
Experimental Procedures, and Supplemental References and can be found
with this article online at doi:10.1016/j.cmet.2012.01.016.
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